Results from a randomized phase II study presented Saturday at the American Society of Clinical Oncology (ASCO) annual meeting indicates there might be a new drug on the horizon for men with advanced prostate cancer. OncoGenex Pharmaceuticals drug known as OGX-011 extended the survival of patients with advanced prostate cancer by almost seven months in [...]
Prostate cancer and diet has been strongly link for a while. We are told to eat a Mediterranean style diet or to become a vegetarian. Being over weight has been strongly linked to having a prostate cancer recurrence. This week's online edition of the journal Cancer Prevention Research states that cutting back on carbohydrates appears [...]
Once we become hormone refractory (HRPC) there remains only one approved drug to treat our prostate cancer, docetaxel. As with hormone therapy (ADT) docetaxel also stops working after a period. There have been different strategies used to try to deal with this untenable situation, including the use of docetaxel on an intermittent schedule. A recent [...]
Urinary incontinence is a common problem suffered by many of us post both surgery and radiation therapy for prostate cancer. The degree of incontinence varies from no problem all the way to having no control of the urinary function. Men having surgery find that as time progresses post treatment, they do regain levels of urinary [...]
HIFU (high-intensity focused ultrasound) is one of the newer treatments for prostate cancer. Although not yet approved in the United States it has received a lot of press and growing popularity as a primary treatment option. There are a number of European countries already using it as a regular treatment modality and there are a [...]